Zobrazeno 1 - 10
of 5 503
pro vyhledávání: '"peripheral T cell lymphoma"'
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 10785-10800 (2024)
Jia-Yu Liu,1 Chia-Hung Yen,2,3 Ya-Fan Lin,4 Yin-Hsun Feng,5 Yi-Ping Fang1,6,7 1School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; 2Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical U
Externí odkaz:
https://doaj.org/article/00a415f531674b8da95a3bca9eca35c1
Publikováno v:
Cancer Biology & Medicine, Vol 21, Iss 9, Pp 754-768 (2024)
Genome sequencing has revealed frequent mutations in Ras homolog family member A (RHOA) among various cancers with unique aberrant profiles and pathogenic effects, especially in peripheral T-cell lymphoma (PTCL). The discrete positional distribution
Externí odkaz:
https://doaj.org/article/77e44167c03a4f8ab14fed7b3acc49bd
Autor:
Hongye Gao, Zhuoxin Zhang, Jiali Wang, Yannan Jia, Yawei Zheng, Xiaolei Pei, Weihua Zhai, Rongli Zhang, Xin Chen, Qiaoling Ma, Jialin Wei, Donglin Yang, Aiming Pang, Yi He, Sizhou Feng, Hao Zhang, Xin Du, Xianmin Song, Yao Liu, Dehui Zou, Erlie Jiang
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-5 (2024)
Abstract The optimal timing and type of hematopoietic stem cell transplantation (HSCT) for treating peripheral T-cell lymphoma (PTCL) remain controversial. This retrospective real-world study investigated the application pattern and outcomes of HSCT
Externí odkaz:
https://doaj.org/article/a02beb60ff29425c999593524215ca3f
Autor:
Huimin Chen, Ruixue Ma, Qianqian Zhang, Fengyi Lu, Yuhan Ma, Jingxin Zhou, Jiang Cao, Kunming Qi, Zhiling Yan, Wei Sang, Feng Zhu, Haiying Sun, Depeng Li, Zhenyu Li, Hai Cheng, Kailin Xu, Wei Chen
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
ABSTRACTBackground: Peripheral T-cell lymphomas (PTCL) are an aggressive group of mature T-cell neoplasms, often associated with poor outcomes, in part, due to frequent relapsed/refractory disease. The objective of this study was to assess the progno
Externí odkaz:
https://doaj.org/article/ada56b4285714342bd2679a9915c325d
Autor:
Bogyeong Han, Sojung Lim, Jeemin Yim, Young Keun Song, Jiwon Koh, Sehui Kim, Cheol Lee, Young A Kim, Yoon Kyung Jeon
Publikováno v:
Journal of Pathology and Translational Medicine, Vol 58, Iss 2, Pp 59-71 (2024)
Background The classification of nodal peripheral T-cell lymphoma (PTCL) has evolved according to histology, cell-of-origin, and genetic alterations. However, the comprehensive expression pattern of follicular helper T-cell (Tfh) markers, T-cell fact
Externí odkaz:
https://doaj.org/article/73cbca91180c4ac1a34dcc5ef7e85418
Autor:
Satoshi Yamasaki, Hiroatsu Iida, Akio Saito, Morio Matsumoto, Yoshiaki Kuroda, Tohru Izumi, Akiko M. Saito, Hiroaki Miyoshi, Koichi Ohshima, Hirokazu Nagai, Hiromi Iwasaki
Publikováno v:
Hematology Reports, Vol 16, Iss 2, Pp 336-346 (2024)
Romidepsin is an important therapeutic option for patients with peripheral T-cell lymphoma (PTCL). However, the timing of romidepsin administration remains controversial. The objective of this study was to characterize the safety and efficacy of romi
Externí odkaz:
https://doaj.org/article/5dc4c27699d24b06ab94ab4efa6a4af8
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-4 (2024)
Abstract Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of hematological malignancies with poor survival, while treatment options for relapsed or refractory (R/R) disease remain quite limited, with a median progression-free survival of on
Externí odkaz:
https://doaj.org/article/6a4c79b3741149a29c6705b4521b5437
Autor:
Ming-Ci Cai, Shu Cheng, Hong-Mei Jing, Yan Liu, Guo-Hui Cui, Ting Niu, Jian-Zhen Shen, Liang Huang, Xin Wang, Yao-Hui Huang, Li Wang, Peng-Peng Xu, Wei-Li Zhao
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 50, Iss , Pp 101160- (2024)
Summary: Background: Peripheral T-cell lymphoma (PTCL) is a heterogeneous disease with dismal outcomes. We conducted an open-label, phase 2 nonrandomised, externally controlled study to evaluate the efficacy and safety of targeted agents plus CHOP (c
Externí odkaz:
https://doaj.org/article/7de9b0251dbf4d408a2dc6d1d4a01309
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 15, Iss , Pp 100313- (2024)
Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare type of T-cell lymphoma of the gastrointestinal tract that presents an aggressive course. Previously, this entity was named type II T-cell lymphoma associated with enteropathy.
Externí odkaz:
https://doaj.org/article/1acc9c1b60604d87a6de58eaae1e4eed
Autor:
Lingling Wang, Lei Yang, Fangshu Guan, Jing Chen, Yuexin Cheng, Yuqing Miao, Jingsong He, Zhen Cai, He Huang, Yi Zhao
Publikováno v:
Cancer Medicine, Vol 13, Iss 14, Pp n/a-n/a (2024)
Abstract There are limited studies on mutation profiling for Peripheral T‐cell lymphomas (PTCL) in the Chinese population. We retrospectively analyzed the clinical and genetic landscape of 66 newly diagnosed Chinese patients. Targeted next‐genera
Externí odkaz:
https://doaj.org/article/7a17475de33e4f16883b578711361d09